We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.226%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 31.50
IHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 Aug 2020 07:00

RNS Number : 7089V
Inspiration Healthcare Group PLC
11 August 2020
 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group") 

 

Trading Update

 

 

Inspiration Healthcare Group plc (AIM:IHC), the global medical technology company, is pleased to give a trading update for the six months ended 31 July 2020.

 

In line with the statement made at the Annual General Meeting, the Group has continued to enjoy a very strong start to the year with underlying revenues in the first six months of the financial year circa 30 per cent ahead of those achieved in the same period last year.

In addition, the Group has a healthy order book which has been augmented by several unexpected opportunities as a result of the Covid-19 epidemic and the award of contracts to supply ventilators and ancillary services to the NHS. As previously reported, the supply of these ventilators has been made difficult by a number of factors outside of the Group's control. However, the Company can report that approximately 40 per cent of the value of the contracts have been supplied and it continues to work hard to supply the balance to the NHS.

In June 2020, we announced our intention to acquire S.L.E., a leader in the design and manufacture of ventilators for neonatal intensive care, which generated revenues of over £16 million and pre-tax profits of £1.5 million last year. Funded by a number of new and existing institutional investors, the management team and private investors, we were pleased to complete the acquisition of S.L.E. in early July which we expect will be earnings enhancing in the short to medium term as well as delivering significant commercial synergies.

 

Neil Campbell, Chief Executive Officer, commented, "Since completion, the integration of S.L.E. has proceeded according to plan and, with the recently announced changes to the senior management team, we are excited about the prospects of the enlarged group. When taking the orders from the NHS for ventilators as a result of the Covid-19 epidemic into account we are well placed to deliver significantly increased revenues. Additionally, this year has had some large contracts and one off opportunities that have resulted in sales being first half weighted. Given the strong first half performance of the underlying business we are confident that we will achieve market expectations for the current financial year." 

 

This announcement contains inside information for the purposes on Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Enquiries:

 

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Jon Ballard, Chief Financial Officer

Tel: 01455 840555

 

Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly

Stephen Keys

Cameron MacRitchie

Tel: 0207 397 8900

 

Cadogan PR 

Alex Walters

alex.walters@cadoganpr.com

Tel: 07771 713608

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

 

Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally the Company has its own range of products for maintaining normothermia pre- during and post-surgery.

 

In September 2019, the company acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables for £4 million and in June 2020 the company acquired S.L.E. a leading global provider of neonatal ventilation products for £18 million. Over 90 per cent. of S.L.E.'s revenues are generated from sales outside of the UK with a significant proportion of these in Asia Pacific and the Middle East. When combined, the Group generates approximately 60 per cent of its revenue from exports.

 

With product availability extending to over [50] countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

 

In the UK and Ireland the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

 

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKKBBFBKDKFD
Date   Source Headline
9th Apr 20247:00 amRNSGrant of Options under Sharesave Scheme
1st Feb 202411:33 amRNSGrant of Covenant Waiver
31st Jan 20247:00 amRNSTrading update
18th Jan 20247:00 amRNSMDSAP certification
15th Jan 20243:04 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSStrategic acquisition of Airon Corporation
7th Dec 20237:00 amRNSDirectorate Change
2nd Nov 20237:00 amRNSLaunch of SLE1500 Non-Invasive Ventilator
31st Oct 202310:18 amRNSHolding(s) in Company
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSDirector/PDMR Shareholding
12th Oct 20237:00 amRNSShareSoc investor presentation
3rd Oct 20237:00 amRNSHalf-year Report
22nd Sep 20237:00 amRNSInvestor results presentation
31st Aug 20237:00 amRNSTrading update
12th Jul 202310:45 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSChange of Registered Office
27th Jun 202312:20 pmRNSResult of AGM
27th Jun 20237:00 amRNSAGM Statement
22nd Jun 20237:00 amRNSAppointment of Non-Executive Director
13th Jun 20232:00 pmRNSInvestor presentation
12th Jun 20237:00 amRNSCFO appointment
9th Jun 20237:00 amRNSGrant of Options
5th Jun 20235:13 pmRNSHolding(s) in Company
5th Jun 20237:00 amRNSHolding(s) in Company
2nd Jun 20237:00 amRNSNotice of AGM and posting of Annual Report
1st Jun 20233:27 pmRNSAIM Rule 17 Schedule Two (g) Update
1st Jun 20238:55 amRNSHolding(s) in Company
24th May 20237:00 amRNSAppointment of Nominated Adviser and Broker
17th May 20237:00 amRNSMello investor conference
4th May 20237:00 amRNSInvestor Day
3rd May 20237:00 amRNSFinal Results
6th Apr 20235:53 pmRNSGrant of Options
3rd Apr 20235:53 pmRNSGrant of Options
31st Mar 20236:27 pmRNSExercise of Options & Issue of Equity
23rd Mar 20237:00 amRNSLaunch of range extension of neonatal ventilators
1st Mar 20237:00 amRNSChange of Website
17th Feb 20232:05 pmRNSTR1 Notification
16th Feb 20237:00 amRNSTrading Update
9th Dec 20222:27 pmRNSTR1 Notification
8th Dec 20221:10 pmRNSTR1 Notification
5th Dec 20227:00 amRNSBoard Changes
30th Nov 202210:28 amRNSDirector / PDMR Dealing
28th Nov 20222:05 pmRNSSecond Price Monitoring Extn
28th Nov 20222:00 pmRNSPrice Monitoring Extension
28th Nov 20229:05 amRNSSecond Price Monitoring Extn
28th Nov 20229:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.